Stockreport

AbbVie acquires Cerevel Therapeutics for $8.7bn [Yahoo! Finance]

Cerevel Therapeutics Holdings, Inc.  (CERE) 
PDF In December 2023, the companies signed a definitive agreement under which AbbVie agreed to acquire Cerevel for $45 per share in cash. Cerevel focuses on creating ther [Read more]